Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans. | Drug Metab Pharmacokinet | 2018 | 29241692 | PubTator, text mining | PubMed |
| Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate. | Biopharm Drug Dispos | 2018 | 29240983 | PubTator, text mining | PubMed |
| Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Carcinogenesis | 2018 | 29228205 | PubTator, text mining | PubMed |
| Pharmacogenetic Analysis of the Model-Based Pharmacokinetics of Five Anti-HIV Drugs: How Does This Influence the Effect of Aging? | Clin Transl Sci | 2018 | 29205871 | PubTator, text mining | PubMed |
| Protein Abundance of Clinically Relevant Drug-Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens. | Clin Pharmacol Ther | 2018 | 29205295 | PubTator, text mining | PubMed |
| Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon. | Br J Haematol | 2018 | 29205277 | PubTator, text mining | PubMed |
| Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism. | Toxicol Lett | 2018 | 29203276 | PubTator, text mining | PubMed |
| Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype. | Forensic Sci Int Genet | 2018 | 29190510 | PubTator, text mining | PubMed |
| Effect of non-prohibited drugs on the phase II metabolic profile of morphine. An in vitro investigation for doping control purposes. | Drug Test Anal | 2018 | 29172026 | PubTator, text mining | PubMed |
| Prediction of metabolism-induced hepatotoxicity on three-dimensional hepatic cell culture and enzyme microarrays. | Arch Toxicol | 2018 | 29167929 | PubTator, text mining | PubMed |
| Identification of cytochrome P450 isoforms involved in the metabolism of artocarpin and assessment of its drug-drug interaction. | Biomed Chromatogr | 2018 | 29166542 | PubTator, text mining | PubMed |
| Identification of Uridine 5'-Diphosphate-Glucuronosyltransferases Responsible for the Glucuronidation of Mirabegron, a Potent and Selective β3-Adrenoceptor Agonist, in Human Liver Microsomes. | Eur J Drug Metab Pharmacokinet | 2018 | 29164523 | PubTator, text mining | PubMed |
| Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions . | Drug Metab Dispos | 2018 | 29138287 | PubTator, text mining | PubMed |
| Using Physiologically Based Pharmacokinetic Modeling for Mechanistic Insight: Cases of Reverse Translation. | Clin Transl Sci | 2018 | 29084377 | PubTator, text mining | PubMed |
| Metabolism of megestrol acetate in vitro and the role of oxidative metabolites. | Xenobiotica | 2018 | 29050522 | PubTator, text mining | PubMed |
| Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex. | Eur J Pharm Sci | 2018 | 29030176 | PubTator, text mining | PubMed |
| Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients. | Brain Dev | 2018 | 28958730 | PubTator, text mining | PubMed |
| Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease. | Expert Rev Clin Pharmacol | 2018 | 28905671 | PubTator, text mining | PubMed |
| Influence of substrates on the in vitro kinetics of steviol glucuronidation and interaction between steviol glycosides metabolites and UGT2B7. | Int J Food Sci Nutr | 2018 | 28903608 | PubTator, text mining | PubMed |
| Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury. | Arch Toxicol | 2018 | 28762043 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=61